Trial Profile
Clinical Trials Insight: 700029261
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2007
Price :
$35
*
At a glance
- Drugs Iclaprim (Primary)
- Indications Chlamydial infections; Gonorrhoea; Nosocomial infections; Nosocomial pneumonia; Skin and soft tissue infections
- Focus Adverse reactions
- Sponsors Arpida
- 13 Dec 2007 Status change
- 13 Dec 2007 New trial record.